Quest Diagnostics, Inc. (DGX)
241.89
-1.39
(-0.57%)
USD |
NYSE |
Oct 23, 16:00
241.89
0.00 (0.00%)
After-Hours: 20:00
Quest Diagnostics Net Income (Quarterly) : 324.00M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 324.00M |
| June 30, 2026 | 333.00M |
| March 31, 2026 | 263.00M |
| December 31, 2025 | 256.00M |
| September 30, 2025 | 257.00M |
| June 30, 2025 | 295.00M |
| March 31, 2025 | 234.00M |
| December 31, 2024 | 234.00M |
| September 30, 2024 | 236.00M |
| June 30, 2024 | 239.00M |
| March 31, 2024 | 207.00M |
| December 31, 2023 | 205.00M |
| September 30, 2023 | 235.00M |
| June 30, 2023 | 248.00M |
| March 31, 2023 | 216.00M |
| December 31, 2022 | 116.00M |
| September 30, 2022 | 274.00M |
| June 30, 2022 | 249.00M |
| March 31, 2022 | 372.00M |
| December 31, 2021 | 412.00M |
| September 30, 2021 | 525.00M |
| June 30, 2021 | 647.00M |
| March 31, 2021 | 489.00M |
| December 31, 2020 | 606.00M |
| September 30, 2020 | 589.00M |
| Date | Value |
|---|---|
| June 30, 2020 | 192.00M |
| March 31, 2020 | 106.00M |
| December 31, 2019 | 264.00M |
| September 30, 2019 | 225.00M |
| June 30, 2019 | 219.00M |
| March 31, 2019 | 175.00M |
| December 31, 2018 | 138.00M |
| September 30, 2018 | 226.00M |
| June 30, 2018 | 233.00M |
| March 31, 2018 | 188.00M |
| December 31, 2017 | 266.00M |
| September 30, 2017 | 174.00M |
| June 30, 2017 | 207.00M |
| March 31, 2017 | 174.00M |
| December 31, 2016 | 167.00M |
| September 30, 2016 | 203.00M |
| June 30, 2016 | 208.00M |
| March 31, 2016 | 115.00M |
| December 31, 2015 | 200.00M |
| September 30, 2015 | 352.00M |
| June 30, 2015 | 128.00M |
| March 31, 2015 | 70.00M |
| December 31, 2014 | 195.00M |
| September 30, 2014 | 138.00M |
| June 30, 2014 | 142.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 299.10M |
| DaVita, Inc. | 343.22M |
| OPKO Health, Inc. | -8.416M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.238M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.097B |
| Total Expenses (Quarterly) | 2.787B |
| EPS Diluted (Quarterly) | 2.768 |
| Enterprise Value | 32.49B |
| Gross Profit Margin (Quarterly) | 32.48% |
| Profit Margin (Quarterly) | 10.46% |
| Earnings Yield | 4.15% |
| Operating Earnings Yield | 6.45% |
| Normalized Earnings Yield | 4.553 |